357 related articles for article (PubMed ID: 12465743)
21. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
Meierhenrich R; Jedicke H; Voigt A; Lange H
Clin Nephrol; 1996 Feb; 45(2):90-7. PubMed ID: 8846536
[TBL] [Abstract][Full Text] [Related]
22. An underappreciated problem in renal transplant recipients: anemia.
Unal A; Sipahioglu MH; Akcakaya M; Tokgoz B; Sav T; Oymak O; Utas C
Transplant Proc; 2008 Jun; 40(5):1399-403. PubMed ID: 18589116
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure.
Kim MK; Baek KH; Lim DJ; Kim YK; Kang MI; Lee KW; Song KH
J Diabetes Complications; 2010; 24(2):90-5. PubMed ID: 19303331
[TBL] [Abstract][Full Text] [Related]
25. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
26. [Erythropoietin: a study of its use in oncohematology].
Fernández Martín JM; Villa Rubio A; Cameán Fernández M; Borrero Rubio JM; Martínez Díaz C; Díaz Navarro J; Moreno Sánchez FC; Serrano Ruiz FJ
Farm Hosp; 2004; 28(1):20-8. PubMed ID: 15012175
[TBL] [Abstract][Full Text] [Related]
27. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
28. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
29. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].
Ogawa T
Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780
[TBL] [Abstract][Full Text] [Related]
30. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
31. Serum erythropoietin levels in the elderly.
Kario K; Matsuo T; Nakao K
Gerontology; 1991; 37(6):345-8. PubMed ID: 1765284
[TBL] [Abstract][Full Text] [Related]
32. Serum erythropoietin titers in hematological malignancies and related diseases.
Urabe A; Mitani K; Yoshinaga K; Iki S; Yagisawa M; Ohbayashi Y; Takaku F
Int J Cell Cloning; 1992 Nov; 10(6):333-7. PubMed ID: 1460322
[TBL] [Abstract][Full Text] [Related]
33. Reduced erythropoietin secretion in senile anemia.
Kario K; Matsuo T; Kodama K; Nakao K; Asada R
Am J Hematol; 1992 Dec; 41(4):252-7. PubMed ID: 1288287
[TBL] [Abstract][Full Text] [Related]
34. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
35. [Erythropoietin determination in clinical medicine].
Urabe A
Rinsho Byori; 1993 Apr; 41(4):361-5. PubMed ID: 8350498
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.
Arslan M; Evrensel T; Kurt E; Demiray M; Ercan I; Kanat O; Ozkan A; Manavoglu O
Neoplasma; 2005; 52(1):43-5. PubMed ID: 15739025
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum erythropoietin detection in patients with cancer-related anemia].
Li LB; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):954-5. PubMed ID: 13129732
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin measurements in severely traumatized patients.
Vialet R; Ventré C; Leone M; Conforto C; Martin C
Acta Anaesthesiol Scand; 2008 May; 52(5):601-4. PubMed ID: 18419712
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin production rate in phlebotomy-induced acute anemia.
Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
Biopharm Drug Dispos; 2004 Dec; 25(9):389-97. PubMed ID: 15529399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
